Jasna Banković

1.0k total citations
34 papers, 845 citations indexed

About

Jasna Banković is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jasna Banković has authored 34 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Jasna Banković's work include Drug Transport and Resistance Mechanisms (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer-related Molecular Pathways (5 papers). Jasna Banković is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer-related Molecular Pathways (5 papers). Jasna Banković collaborates with scholars based in Serbia, Greece and Spain. Jasna Banković's co-authors include Nikola Tanić, Milica Pešić, Sabera Ruždijić, Ana Podolski-Renić, Tijana Stanković, Jelena Dinić, Jelena Stojšić, Zorica Milošević, Ivanka Marković and Ivana Aljančić and has published in prestigious journals such as PLoS ONE, Experimental Cell Research and Phytochemistry.

In The Last Decade

Jasna Banković

34 papers receiving 834 citations

Peers

Jasna Banković
Muntasir Mamun Majumder Finland
Thomas Grombacher Germany
Jinmei Jin China
Guohui Cui China
Linda Rickardson Sweden
Ramachandran Rashmi United States
Ning Ji China
ŞERBAN COMŞA Romania
Brian D. Koh United States
Tijana Stanković Serbia
Muntasir Mamun Majumder Finland
Jasna Banković
Citations per year, relative to Jasna Banković Jasna Banković (= 1×) peers Muntasir Mamun Majumder

Countries citing papers authored by Jasna Banković

Since Specialization
Citations

This map shows the geographic impact of Jasna Banković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasna Banković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasna Banković more than expected).

Fields of papers citing papers by Jasna Banković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasna Banković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasna Banković. The network helps show where Jasna Banković may publish in the future.

Co-authorship network of co-authors of Jasna Banković

This figure shows the co-authorship network connecting the top 25 collaborators of Jasna Banković. A scholar is included among the top collaborators of Jasna Banković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasna Banković. Jasna Banković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milošević, Zorica, Jasna Banković, Jelena Dinić, et al.. (2018). Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma. Cellular Oncology. 41(4). 409–426. 24 indexed citations
2.
Banković, Jasna, et al.. (2018). Association of overexpressed MYC gene with altered PHACTR3 and E2F4 genes contributes to non-small cell lung carcinoma pathogenesis. Journal of Medical Biochemistry. 38(2). 188–195. 14 indexed citations
3.
Podolski-Renić, Ana, Jasna Banković, Jelena Dinić, et al.. (2017). DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells. European Journal of Pharmaceutical Sciences. 105. 159–168. 18 indexed citations
4.
Banković, Jasna, Evangelia Sereti, Sofija Jovanović Stojanov, et al.. (2017). Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors. Investigational New Drugs. 35(6). 718–732. 10 indexed citations
5.
Pešić, Milica, Jelena Dinić, Jasna Banković, et al.. (2016). Simple avarone mimetics as selective agents against multidrug resistant cancer cells. European Journal of Medicinal Chemistry. 118. 107–120. 5 indexed citations
6.
Podolski-Renić, Ana, Zorica Milošević, Jelena Dinić, et al.. (2016). Mutual regulation and targeting of multidrug resistance and cancer stem phenotype. MedChemComm. 7(12). 2265–2281. 2 indexed citations
7.
Podolski-Renić, Ana, Jelena Dinić, Tijana Stanković, et al.. (2015). Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin. Experimental Cell Research. 335(2). 248–257. 17 indexed citations
8.
Milošević, Zorica, Jasna Banković, Jelena Dinić, et al.. (2015). Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients’ outcome. Tumor Biology. 36(11). 8773–8780. 14 indexed citations
9.
Dinić, Jelena, Ana Podolski-Renić, Tijana Stanković, Jasna Banković, & Milica Pešić. (2015). New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer. Current Pharmaceutical Design. 21(38). 5589–5604. 35 indexed citations
10.
Stanković, Tijana, Jasna Banković, Jelena Dinić, et al.. (2014). Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples. Biomedicine & Pharmacotherapy. 68(5). 521–526. 10 indexed citations
11.
Milošević, Zorica, Milica Pešić, Tijana Stanković, et al.. (2014). Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma. Translational research. 164(5). 411–423. 46 indexed citations
12.
Stojšić, Jelena, Tijana Stanković, Jelena Dinić, et al.. (2014). Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma. Experimental and Molecular Pathology. 98(1). 27–32. 3 indexed citations
13.
Liu, Qing, David Manzano, Nikola Tanić, et al.. (2014). Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway. Metabolic Engineering. 23. 145–153. 67 indexed citations
14.
Banković, Jasna, et al.. (2013). Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients. PLoS ONE. 8(12). e82108–e82108. 25 indexed citations
15.
Podolski-Renić, Ana, Milka Jadranin, Tijana Stanković, et al.. (2013). Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing. Cancer Chemotherapy and Pharmacology. 72(3). 683–697. 31 indexed citations
16.
Banković, Jasna, Nebojša T. Milošević, Tijana Stanković, et al.. (2012). Genomic instability and p53 alterations in patients with malignant glioma. Experimental and Molecular Pathology. 93(2). 200–206. 22 indexed citations
17.
Pešić, Milica, Jasna Banković, Ivana Aljančić, et al.. (2011). New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides. Food and Chemical Toxicology. 49(12). 3165–3173. 31 indexed citations
18.
Podolski-Renić, Ana, et al.. (2011). The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines. Biomedicine & Pharmacotherapy. 65(5). 345–353. 64 indexed citations
19.
Banković, Jasna, et al.. (2009). Identification of genes associated with non-small-cell lung cancer promotion and progression. Lung Cancer. 67(2). 151–159. 81 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muntasir Mamun Majumder Breakdown of academic impact, for papers by Thomas Grombacher Breakdown of academic impact, for papers by Jinmei Jin Breakdown of academic impact, for papers by Guohui Cui Breakdown of academic impact, for papers by Linda Rickardson Breakdown of academic impact, for papers by Ramachandran Rashmi Breakdown of academic impact, for papers by Ning Ji Breakdown of academic impact, for papers by ŞERBAN COMŞA Breakdown of academic impact, for papers by Brian D. Koh Breakdown of academic impact, for papers by Tijana Stanković
Rankless by CCL
2026